Fedratinib inhibits ovarian cancer progression by downregulating QPCT expression
{{output}}
Objective: Among gynecological malignant tumors, ovarian cancer is one of the most common, and the death rate is the highest. However, most ovarian cancer patients will be resistant to the application of Olaparib. Searching for n... ...